Shuguang Pang

Statistics

Publications

Citations

379

H-Index

Active since

2015

Affiliations

Jinan Central Hospital(Current)

First Affiliated Hospital of Henan University of Science and Technology

Peking University

Jiangxi Pingxiang People's Hospital

Innovative Biologics (United States)

Shuguang Pang is an author at Jinan Central Hospital specializing in diabetes mellitus, clinical pharmacology, and glucagon-like peptide 1 receptor agonism.

ORCID

Publications per year

2015–2024

Publications

Intensive Blood-Pressure Control in Patients with Type 2 Diabetes

Yufang Bi, Mian Li, Jieli Lu et al. · New England Journal of Medicine · 2024 · 193 citations

Medicine, Cardiology, Internal Medicine +17

A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity

Linong Ji, Hongwei� Jiang, Zhifeng Cheng et al. · Nature Communications · 2023 · 95 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes

Hongwei� Jiang, Shuguang Pang, Yawei Zhang et al. · Nature Communications · 2022 · 45 citations · Full text

Medicine, Endocrinology, Pharmacology +17

GABA Analogue HSK16149 in Chinese Patients With Diabetic Peripheral Neuropathic Pain

Xiaohui Guo, Tingting Zhang, Wei‐Fang Zeng et al. · JAMA Network Open · 2024 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

GLP-1-Exendin-4/IgG4 (Fc) Fusion Protein as a Novel Drug for Diabetes Treatment

Yandong Gan, Ningning Dang, Zhenzhen Qu et al. · Experimental and Clinical Endocrinology & Diabetes · 2015 · 15 citations

Life Sciences, Endocrinology, Molecular Biology +15

1–5 of 6